Abstract
Xanthomonas maltophilia is being increasingly recognized as an opportunistic pathogen in debilitated patients. We report a case of postoperative meningitis due to X. maltophilia and review the cases of X. maltophilia meningitis reported in the literature. Because X. maltophilia is often resistant to multiple beta-lactam agents, including cephalosporins and imipenem, trimethoprim-sulfamethoxazole appears to be the drug of choice for treatment of X. maltophilia meningitis.
MeSH terms
-
Cerebrospinal Fluid / microbiology
-
Gram-Negative Bacterial Infections / complications*
-
Gram-Negative Bacterial Infections / drug therapy
-
Humans
-
Hydrocephalus / surgery
-
Male
-
Meningeal Neoplasms / surgery
-
Meningioma / surgery
-
Meningitis, Bacterial / drug therapy
-
Meningitis, Bacterial / microbiology*
-
Middle Aged
-
Postoperative Complications / drug therapy
-
Postoperative Complications / microbiology*
-
Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use
-
Ventriculoperitoneal Shunt
-
Xanthomonas / growth & development
-
Xanthomonas / isolation & purification*
Substances
-
Trimethoprim, Sulfamethoxazole Drug Combination